entertainment -WSS

entertainment

author：comprehensive 2025-09-30 07:38:46 - browse：469

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Steward Health Care files for bankruptcy

WSS

Brain worms: The science behind RFK Jr.'s parasitic infection

Brain worms: The science behind RFK Jr.'s parasitic infection

Study: AI not yet building 'n

Google says AlphaFold 3 can map a vast universe of biomolecules

Questions and answers about ramping up H5N1 bird flu vaccine

Software glitch causes Tandem insulin pump to shutdown, FDA warns

knowledge

entertainment

A looming test for neoantigen cancer vaccines

hotspot

Alkermes shareholders re

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

United colonoscopy coverage change 'may cost lives,' doctors say

FDA poised to publish guidelines for clinical trial diversity

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Use wet bulb globe temperature, not heat index, to protect workers

Continuity nursing helped my family in our darkest PICU moments

Elevance, private equity launch primary care company

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bird flu surveillance in wastewater gets boost from consortium

focus

Eyeing GLP

Bird flu outbreak in cows is latest avian flu curveball

Making the case for fair compensation in clinical trials

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

For longer

Researchers on aging grapple with how to calculate biological age

knowledge

hotspot

hotspot

explore